Literature DB >> 7127685

Potentiating and depressive effects of ouabain and potassium-free solutions on rat mesenteric resistance vessels.

M J Mulvany, H Nilsson, J A Flatman, N Korsgaard.   

Abstract

We have investigated the in vitro effects of ouabain and K-free solutions on some pharmacological and electrophysiological properties of rat mesenteric resistance vessels (internal diameter approximately 190 micrometers). Vessels were mounted as ring preparations on a myograph capable of measuring their isometric wall tension. In normal saline solutions, vessels did not exhibit any tone and had a membrane potential of -54 mV. Both 1 mM ouabain and K-free solutions caused a transient depolarization of 5-8 mV; thereafter the membrane slowly depolarized to about -45 mV after 30 minutes. There was no mechanical response to ouabain, but K-free solutions caused a transient development of tension which could be inhibited by phentolamine (1 microM). In norepinephrine-activated vessels, exposure to ouabain or K-free solutions caused a small depolarization and an increase in tension. Long-term (30-minute) exposure to 1 mM ouabain or K-free solutions reduced the amplitude of norepinephrine responses and, for the lower (but not the higher) norepinephrine concentrations, the membranes were about 14 mV more depolarized than control. The mechanical responses to a cocktail of norepinephrine in a high potassium solution were, however, unaffected. Re-exposure to normal saline solution produced a transient hyperpolarization and transiently eliminated the norepinephrine response, but thereafter the membrane potential and response returned to normal. The results indicate that ouabain and K-free solutions can have both short-term potentiating and long-term depressive effects on the mechanical response of rat mesenteric resistance vessels to norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127685     DOI: 10.1161/01.res.51.4.514

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Effect of ouabain on tone, membrane potential and sodium efflux compared with [3H]ouabain binding in rat resistance vessels.

Authors:  C Aalkjaer; M J Mulvany
Journal:  J Physiol       Date:  1985-05       Impact factor: 5.182

2.  Glimpses of the mechanisms of hypertension.

Authors:  P F Semple; A F Lever
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11

3.  Sodium metabolism in rat resistance vessels.

Authors:  C Aalkjaer; M J Mulvany
Journal:  J Physiol       Date:  1983-10       Impact factor: 5.182

4.  The role of membrane depolarization in the contractile response of the rabbit basilar artery to 5-hydroxytryptamine.

Authors:  C J Garland
Journal:  J Physiol       Date:  1987-11       Impact factor: 5.182

5.  The interaction of canrenone with the Na+,K+ pump in human red blood cells.

Authors:  R P Garay; J Diez; C Nazaret; G Dagher; J P Abitbol
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

6.  Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia.

Authors:  Young Soo Han; Frank V Brozovich
Journal:  J Vasc Res       Date:  2012-11-21       Impact factor: 1.934

7.  The microtubule network enables Src kinase interaction with the Na,K-ATPase to generate Ca2+ flashes in smooth muscle cells.

Authors:  Salomé Rognant; Violetta V Kravtsova; Elena V Bouzinova; Elizaveta V Melnikova; Igor I Krivoi; Sandrine V Pierre; Christian Aalkjaer; Thomas A Jepps; Vladimir V Matchkov
Journal:  Front Physiol       Date:  2022-09-23       Impact factor: 4.755

Review 8.  Specialized Functional Diversity and Interactions of the Na,K-ATPase.

Authors:  Vladimir V Matchkov; Igor I Krivoi
Journal:  Front Physiol       Date:  2016-05-25       Impact factor: 4.566

9.  The Na,K-ATPase-Dependent Src Kinase Signaling Changes with Mesenteric Artery Diameter.

Authors:  Lin Zhang; Christian Aalkjaer; Vladimir V Matchkov
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.